Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 Jun 24;28(1):207.
doi: 10.1186/s13054-024-04995-z.

Desorption in hemoadsorption therapies: a call for more data

Affiliations
Comment

Desorption in hemoadsorption therapies: a call for more data

Aron Jansen et al. Crit Care. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Comment on

References

    1. Buhlmann A, Erlebach R, Müller M, David S, Kleinert E-M, Erlebach R, Andermatt R, Hofmaenner DA, Mueller M, Schuepbach R, et al. The phenomenon of desorption: What are the best adsorber exchange intervals? Crit Care. 2024;28(1):178. doi: 10.1186/s13054-024-04968-2. - DOI - PMC - PubMed
    1. Jansen A, Waalders NJB, van Lier DPT, Kox M, Pickkers P. CytoSorb hemoperfusion markedly attenuates circulating cytokine concentrations during systemic inflammation in humans in vivo. Crit Care. 2023;27(1):117. doi: 10.1186/s13054-023-04391-z. - DOI - PMC - PubMed
    1. Mitzner S, Kogelmann K, Ince C, Molnár Z, Ferrer R, Nierhaus A. Adjunctive hemoadsorption therapy with cytosorb in patients with septic/vasoplegic shock: a best practice consensus statement. J Clin Med. 2023;12(23):7199. doi: 10.3390/jcm12237199. - DOI - PMC - PubMed
    1. Becker S, Lang H, Vollmer Barbosa C, Tian Z, Melk A, Schmidt BMW. Efficacy of CytoSorb®: a sysstematic review and meta-analysis. Crit Care. 2023;27(1):215. doi: 10.1186/s13054-023-04492-9. - DOI - PMC - PubMed

LinkOut - more resources